Dr K R Prasanna Kumar

Senior Consultant Radiation Oncology

Cancer (Oncology)

January 1, 2009

Connect with Dr K R Prasanna Kumar

Top Areas of Expertise

Radiotherapy: Proficient in modern external beam techniques, including
2D Conventional Radiotherapy, 3DCRT, IMRT, IGRT
SRT, SBRT, RAPIDARC
X-Knife SRS, Cyberknife SRS
Brachytherapy: Expertise in HDR techniques such as intracavitary, intraluminal, and interstitial brachytherapy.
Comprehensive Cancer Care Services
Preventive cancer screening
Chemotherapy
Lung cancer treatment
Ultrasound-guided cytology
Advanced Equipment: Skilled in using Primer, Artiste, Cyberknife, Gamma Medplus, Oncor, True Beam, and HDR Microselectron.
Treatment Planning Systems: Proficient in Oncentra, BRAINLAB, Multiplan Cyberknife, Eclipse, and MimVista.

Top Treatments Offered

Precision radiotherapy using CyberKnife, TrueBeam, GammaMedplus, Artiste, and specialized machines

Brachytherapy with advanced HDR Microselectron systems

Full-spectrum cancer care including chemotherapy, imaging-guided cytology, and screening services

About Dr K R Prasanna Kumar

Dr. K. R. Prasanna Kumar is a highly skilled Radiation Oncologist with over 16 years of clinical experience at SIMS Hospital. Trained from Madurai Medical College and the National Board, he brings precision-focused cancer care using cutting-edge radiotherapy technologies like CyberKnife and RapidArc. His expertise spans across advanced treatment planning systems and HDR brachytherapy. He is also active in research, holding a thesis on rectal cancer chemoradiation and presentations in national oncology forums.

Educational Qualification:

MBBS, Madurai Medical College, Tamil Nadu (2008)
DNB (Radiotherapy), National Board of Examinations, New Delhi (2013)

Awards:

Awarded Distinction in Biochemistry and Pharmacology (2005).

Publications:

Analysis of Acute Toxicities, Pathological Complete Response, Sphincter Preservation Rate of Preoperative Chemoradiation in Locally Advanced Rectal Cancers (Thesis)
Presented â€˜Role of Cyberknife Radiosurgery in Choroidal Melanomaâ€™ at the TN-PY AROI Conference (2012).Awarded Distinction in Biochemistry and Pharmacology (2005).